$MSTR

Barclays raises Strategy price target to $175, keeps buy rating

Barclays raised its price target for Strategy Inc. (MSTR) to $175 from $160, maintaining an Overweight rating. The bank categorizes MSTR in the US payments and fintech sector. MSTR reported Q2 revenue of $122.4M, up 7% YoY, but net losses were impacted by Bitcoin value changes. MSTR shares closed at $151.47 on October 8, 2026.

Original reporting
Published Oct 9, 2026, 11:37 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 12:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays raises Strategy price target to $175, keeps buy rating — source image
Decision brief

The 30-second read

$MSTRBullishMed
01

Why it matters

The target raise signals a bullish outlook, potentially prompting short‑term buying interest and supporting price appreciation.

02

Market read

Analyst upgrade with a higher price target can move the stock in pre‑market trading and may influence peer valuations in the fintech/crypto space.

03

What to watch

Potential regulatory risks to Bitcoin holdings and the broader fintech competitive landscape.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Barclays re‑issued an Overweight rating on Strategy Inc., raising its 12‑month price target from $160 to $175, citing revenue growth and a new sector classification alongside its Bitcoin treasury.

Company-level read

Ticker impact

$MSTRBullishHigh confidence
Context

Barclays raised its 12‑month price target for Strategy Inc. to $175 and reaffirmed an Overweight rating.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

Barclays' new $175 target implies ~15% upside from recent levels and reflects a bullish view on both the payments fintech angle and Bitcoin holdings.

Market effects

Higher target may lift other fintech and crypto‑exposed stocks as analysts re‑evaluate sector positioning.

U.S. market focus; limited regional effect.

Modest; primarily influences U.S. investors tracking crypto‑linked equities.

Counterpoint

Some investors may remain skeptical of Bitcoin volatility and could view the target as overly optimistic.

Key entities

  • Barclays

    Equity research firm providing the rating and target.

  • Strategy Inc.

    Publicly traded crypto‑focused fintech firm (NASDAQ:MSTR).

Related articles

$CRCLMed

Circle Internet Spikes 7% After Backing OKX at $25B Valuation; Coinbase Rallies 6%, Strategy Climbs 3%

Circle Internet (CRCL) rose 7% to $86.39 after investing in OKX's $25B funding round, which aims for regulatory approval to trade tokenized stocks. Coinbase (COIN) gained 6% to $181.91, and Strategy (MSTR) climbed 3% to $156.40. These crypto-linked equities outperformed the iShares Bitcoin Trust ETF (IBIT) and the broader market. Circle's investment aligns it with OKX's regulatory push, while Coinbase and Strategy's gains are tied to trading volume and crypto asset prices, respectively.

$MSTRMed

Strategy Faces ‘Dilution Drag’ as TD Cowen Raises Bitcoin Forecast to $109,000 - Strategy (NASDAQ:MSTR)

TD Cowen raised its Bitcoin (BTC) price forecast to $109,000 by 2026 and $280,000 by 2029, but kept its price target for Strategy (MSTR) at $260, citing dilution risks. The analysts noted that Strategy's capital structure reduces per-share gains from Bitcoin's price increases. MSTR shares fell 2.5% to $150 on Thursday, with a 73% upside implied by the target. Strategy holds 848,000 BTC, with $4.5 billion in unrealized profit.